ES2063143T3 - Sales de acidos naftalenopropionicos. - Google Patents

Sales de acidos naftalenopropionicos.

Info

Publication number
ES2063143T3
ES2063143T3 ES89311231T ES89311231T ES2063143T3 ES 2063143 T3 ES2063143 T3 ES 2063143T3 ES 89311231 T ES89311231 T ES 89311231T ES 89311231 T ES89311231 T ES 89311231T ES 2063143 T3 ES2063143 T3 ES 2063143T3
Authority
ES
Spain
Prior art keywords
salts
carbon atoms
hydroxyalkyl
acids
naftalenopropionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89311231T
Other languages
English (en)
Inventor
Anthony Frank Kreft
John Henry Musser
James J Bicksler
John William Giberson
Dennis Martin Kubrak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2063143T3 publication Critical patent/ES2063143T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

LA INVENCION CONCIERNE A UNA SAL AMINO ACIDA ACETICA (ALFA)-METIL-6-(2 QUINOLINILMETOXI)-2-NAFTALENA, DONDE EL AMINO ES UN HIDROXIALQUILAMINO DE FORMULA NR1R2R3 DONDE R1 ES HIDROGENO, FENIL, ALQUIL DE 1 A 6 ATOMOS DE CARBONO O HIDROXIALQUIL DE 1 A 6 ATOMOS DE CARBONO, R2 ES HIDROGENO, FENIL, ALQUIL DE 1 A 6 ATOMOS DE CARBONO Y R3 ES HIDROXIALQUIL DE 1 A 12 ATOMOS DE CARBONO. PREFERENTEMENTE LAS SALES SON SAL TROMETAMINA, LAS SALES AMINAS TIENEN UNA ACTIVIDAD INTENSIFICADA SI LA COMPARAS CON LA DE LOS ACIDOS.
ES89311231T 1989-05-12 1989-10-31 Sales de acidos naftalenopropionicos. Expired - Lifetime ES2063143T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/351,119 US4960892A (en) 1988-06-10 1989-05-12 Naphthalenepropionic acid derivatives as anti-inflammatory/anti-allergic agents

Publications (1)

Publication Number Publication Date
ES2063143T3 true ES2063143T3 (es) 1995-01-01

Family

ID=23379653

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89311231T Expired - Lifetime ES2063143T3 (es) 1989-05-12 1989-10-31 Sales de acidos naftalenopropionicos.

Country Status (15)

Country Link
US (1) US4960892A (es)
EP (1) EP0396839B1 (es)
JP (1) JPH02311463A (es)
KR (1) KR900018033A (es)
AT (1) ATE104281T1 (es)
AU (1) AU629868B2 (es)
CA (1) CA1331001C (es)
DE (1) DE68914646T2 (es)
DK (1) DK169545B1 (es)
ES (1) ES2063143T3 (es)
GB (1) GB2231570B (es)
IE (1) IE61967B1 (es)
IL (1) IL92083A0 (es)
NZ (1) NZ231255A (es)
ZA (1) ZA898291B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084575A (en) * 1987-07-31 1992-01-28 American Home Products Corporation Quinoline substituted naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
US5208344A (en) * 1987-07-31 1993-05-04 American Home Products Corporation Naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
JPH0317061A (ja) * 1989-06-13 1991-01-25 Kyorin Pharmaceut Co Ltd 新規環状アントラニル酸酢酸誘導体
EP0540165A1 (en) * 1991-10-03 1993-05-05 Zeneca Limited Alkanoic acid derivatives
ES2058024B1 (es) * 1992-11-10 1995-05-01 Menarini Lab Nuevo derivado arilpropionico, procedimiento de fabricacion del mismo y su utilizacion como analgesico.
ES2124196B1 (es) * 1997-06-04 1999-12-01 Menarini Lab Procedimiento para la fabricacion de una forma farmaceutica semisolida conteniendo dexketoprofeno trometamol y su utilizacion en el tratamiento topico de la inflamacion.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904682A (en) * 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
DE2134672A1 (de) * 1971-07-08 1973-01-25 Josef Dipl Chem Dr Rer N Klosa Wasserloesliches acetylsalicylsaeuresalz, dessen herstellung, zubereitung und anwendung
US4097674A (en) * 1975-03-17 1978-06-27 Syntex Corporation 2-Naphthylacetic acid derivatives
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4754043A (en) * 1985-10-03 1988-06-28 American Home Products Corporation Oxazole and thiazole naphthalenes as antiallergic agents
US4732978A (en) * 1985-10-03 1988-03-22 American Home Products Corporation Novel substituted naphthyloxymethyl quinoline derivatives as anti-inflammatory and antiallergy agents
US4772703A (en) * 1986-01-27 1988-09-20 American Home Products Corporation 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents
AU611699B2 (en) * 1987-07-31 1991-06-20 American Home Products Corporation Naphthalene propionic acid derivatives
IL133435A0 (en) * 1997-06-12 2001-04-30 Northrop Grumman Corp Heat resistant composite structure

Also Published As

Publication number Publication date
GB2231570A (en) 1990-11-21
IL92083A0 (en) 1990-07-12
AU4436189A (en) 1990-11-15
GB2231570B (en) 1992-05-20
EP0396839A2 (en) 1990-11-14
CA1331001C (en) 1994-07-26
KR900018033A (ko) 1990-12-20
DK117590A (da) 1990-11-13
US4960892A (en) 1990-10-02
EP0396839A3 (en) 1991-06-05
EP0396839B1 (en) 1994-04-13
DE68914646T2 (de) 1994-07-21
AU629868B2 (en) 1992-10-15
IE61967B1 (en) 1994-11-30
DK169545B1 (da) 1994-11-28
JPH02311463A (ja) 1990-12-27
ZA898291B (en) 1991-06-26
NZ231255A (en) 1991-02-26
GB8924501D0 (en) 1989-12-20
DE68914646D1 (de) 1994-05-19
IE893519L (en) 1990-11-12
ATE104281T1 (de) 1994-04-15
DK117590D0 (da) 1990-05-10

Similar Documents

Publication Publication Date Title
PT787726E (pt) Novo composto, processo para a sua producao e agente tumoral
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
SE8302694D0 (sv) Immunomodulating agent
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
ES2063143T3 (es) Sales de acidos naftalenopropionicos.
PT81530B (pt) Processo para a resolucao optica de misturas racemicas de acidos alfa-naftil-proplonicos
ES516552A0 (es) Procedimiento para preparar nuevos derivados de etenilimidazol.
PT945430E (pt) N-fenilacetoacetamidas e processo para a sua producao
ES2089097T3 (es) Procedimiento para la fabricacion de derivados de bencilftalacinona y sales de la misma.
PT91145A (pt) Processo para a sintese de amino-acidos opticamente activos
ES2144327T3 (es) Procedimiento para preparar un compuesto de 2-cianobifenilo.
ATE40117T1 (de) O-substituierte 3-oxypyridiniumsalze, verfahren zu ihrer herstellung und ihre verwendung als fungizide fuer den pflanzenschutz.
PT971899E (pt) Compostos de hexa-hidroindenopiridina possuindo actividade antiespermatogenica.
BR8100315A (pt) Processo para a preparacao de esteres de indan-4-ilo de acidos n-alquil-carbamicos, composicoes fungicidas, processo para o combate de fungos e processo para preparar composicoes fungicidas
ATE53378T1 (de) Verfahren zur herstellung von nmonosubstituierten p-phenylendiaminen.
DK501083A (da) Semicarbazider, fremgangsmaade til deres fremstilling samt deres anvendelse
ATE77373T1 (de) Verfahren zur herstellung von chinolinsaeurederivaten.
ATE24507T1 (de) Verfahren zur herstellung von lysergsaeure-estern.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 396839

Country of ref document: ES